Reju Korah
- Endocrinology, Diabetes and Metabolism top 2%
- Molecular Biology
- Surgery top 10%
- Oncology top 5%
- Cancer Research top 5%
- Co-authors
- Tobias CarlingRobert WiederT BrownManju L. PrasadJames M. HealyJohn W. KunstmanRichard P. LiftonJeanMarie Houghton
- Topics
- Cancer, Hypoxia, and Metabolism (17 papers)Adrenal and Paraganglionic Tumors (15 papers)Thyroid Cancer Diagnosis and Treatment (9 papers)
- Journals
- Proceedings of the National Academy of SciencesNature GeneticsThe Journal of Clinical Endocrinology & Metabolism
- Partner nations
- United StatesSwedenGermany
In The Last Decade
Reju Korah
55 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 87
- Endocrinology, Diabetes and Metabolism 653
- Molecular Biology 608
- Surgery 528
- Oncology 463
- Cancer Research 341
Countries citing papers authored by Reju Korah
This map shows the geographic impact of Reju Korah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reju Korah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reju Korah more than expected).
Fields of papers citing papers by Reju Korah
This network shows the impact of papers produced by Reju Korah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reju Korah. The network helps show where Reju Korah may publish in the future.
Co-authorship network of co-authors of Reju Korah
This figure shows the co-authorship network connecting the top 25 collaborators of Reju Korah. A scholar is included among the top collaborators of Reju Korah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reju Korah. Reju Korah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 10 | |
| 4 | 12 | |
| 5 | 8 | |
| 6 | 46 | |
| 7 | 5 | |
| 8 | 10 | |
| 9 | 108 | |
| 10 | 267 | |
| 11 | 65 | |
| 12 | 25 | |
| 13 | Role of RhoA in survival of dormant breast cancer cells. | 2 |
| 14 | 7 | |
| 15 | 23 | |
| 16 | 34 | |
| 17 | 1 | |
| 18 | 10 | |
| 19 | 5 | |
| 20 | 8 |
About Reju Korah
Reju Korah is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism and Genetics, having authored 56 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (17 papers), Adrenal and Paraganglionic Tumors (15 papers) and Thyroid Cancer Diagnosis and Treatment (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (653 citations), Cancer Research (341 citations) and Oncology (463 citations). Reju Korah has collaborated with scholars based in United States, Sweden and Germany. Frequent co-authors include Tobias Carling, Robert Wieder, T Brown, Manju L. Prasad, James M. Healy, John W. Kunstman, Richard P. Lifton, JeanMarie Houghton, C. Christofer Juhlin and Gerald Goh. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Genetics and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.